Immuneering Announces Participation in February Investor Conferences
01 févr. 2024 08h00 HE
|
Immuneering Corporation
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF medicines for broad populations of...
Entera Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
30 janv. 2024 08h30 HE
|
Entera Bio Ltd.
JERUSALEM, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced...
APTIM Selected by U.S. Department of Energy to Decommission Ion Beam Facility
15 août 2023 08h00 HE
|
APTIM
Baton Rouge, La., Aug. 15, 2023 (GLOBE NEWSWIRE) -- The U.S. Department of Energy (DOE) has selected APTIM to deactivate, decommission, and remove (DD&R) the Ion Beam Facility (IBF), a former...
Historic Newsreel Clip: Oppenheimer Issues Warning
21 juil. 2023 22h45 HE
|
UCLA Film & Television Archive
Los Angeles, CA, July 21, 2023 (GLOBE NEWSWIRE) -- Clip from Oct. 26, 1945; 50 seconds: ATOM BOMB SCIENTIST WARNS AMERICA OF DANGERS AHEAD! Research chief of atomic project, Dr. J. Robert...
Creative Mammals Revealed as Animation Studio Behind NBC News Studios' ‘To End All War: Oppenheimer & The Atomic Bomb’
07 juil. 2023 10h00 HE
|
Creative Mammals
Film airs July 9th at 10pm ET on MSNBC; streaming on Peacock Watch the official trailer here ATLANTA, July 07, 2023 (GLOBE NEWSWIRE) -- Creative Mammals is proud to announce its first...
H&R Block to Participate in the Oppenheimer 23rd Annual Consumer Growth & E-Commerce Conference
30 mai 2023 16h35 HE
|
HRB Tax Group, Inc.
KANSAS CITY, Mo., May 30, 2023 (GLOBE NEWSWIRE) -- H&R Block, Inc. (NYSE: HRB) (the “Company”) today announced that Jeff Jones, President and Chief Executive Officer, and Tony Bowen, Chief...
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
14 mars 2023 08h30 HE
|
Novan, Inc.
DURHAM, N.C., March 14, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
08 mars 2023 07h00 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
Processa Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
07 mars 2023 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, March 07, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), the developer of the Next Generation Chemotherapy drugs that will provide...
Fortress Biotech to Participate in Two March 2023 Investor Conferences
07 mars 2023 08h00 HE
|
Fortress Biotech, Inc.
MIAMI, March 07, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing...